
MUHC designated first provincial establishment for islet cell transplants for patients with type 1 diabetes
Non-invasive procedure allows patients to live without fear...

RI-MUHC study highlights the role of fat metabolism enzyme in aggressive prostate cancer
A fatty acid metabolism enzyme drives prostate cancer aggressiveness...

Taking opioids at home after surgery: More harms than benefits
A new study conducted at the RI-MUHC concludes that prescribing opioid analgesics at discharge after surgery does not reduce postoperative pain...

New study: Montreal researchers identify three drugs that could reduce mortality in severely ill COVID-19 patients
Researchers from the RI-MUHC and the McGill Genome Centre examine...

The RI-MUHC is first in Canada to adopt sentinel-free animal health monitoring
One of ten champion institutions in North America, the RI-MUHC has completely switched to a new program...

New study shows associations between air pollution and respiratory health in Canada
RI-MUHC researchers demonstrate that exposure to relatively low levels of air pollution in Canada is associated...

Type 1 diabetes: a combination therapy improves glucose control and performance of artificial pancreases
A publication in Nature Medicine by RI-MUHC researchers describes...

RI-MUHC leads study to identify a novel mechanism driving aggressive prostate cancer
This international research collaboration may lead to a shift in the clinical management of patients...

Improving the performance of rapid tests through clear instructions
Researchers at the RI-MUHC investigate whether rapid antigenic detection tests for COVID-19 could be adequately used in the workplace.

New collaboration to improve the detection of type 2 diabetes in high-risk patients starts in Montreal, Quebec
The project will use artificial intelligence (A.I.), wearable...